The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Share News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 576.00
Bid: 514.00
Ask: 596.00
Change: 0.00 (0.00%)
Spread: 82.00 (15.953%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 576.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bloomsbury reports record-breaking first-half earnings

Thu, 26th Oct 2023 08:12

(Sharecast News) - Bloomsbury Publishing reported record-breaking earnings in its interim results on Thursday, marking the fourth consecutive half-year of double-digit growth in both revenue and profit.

The London-listed independent publisher said revenue was up 11% year-on-year in the six months ended 31 August, reaching £136.7m, while profit before tax advanced 8% to £14m.

Diluted earnings per share jumped 11% to 13.66p, while net cash declined 6% to end the period at £39.1m.

The board declared a 162% surge in the interim dividend to 3.7p per share.

Within the consumer division, Bloomsbury recorded robust revenue growth of 17%, reaching £89.4m, while profits before tax and highlighted items increased 26% to £11.2m.

The firm reported 8% growth in Adult Trade revenue, amounting to £27.6m, with a profit before tax and highlighted items of £0.1m.

Children's Trade revenue meanwhile saw substantial growth of 22% to £61.7m, accompanied by a 29% increase in profit before tax and highlighted items to £11.1m.

Bloomsbury celebrated remarkable sales growth of titles by Sarah J. Maas, surging 79%, while the enduring popularity of Harry Potter remained evident, with robust sales even 26 years after its initial publication.

Within the non-consumer division, the company recorded modest revenue growth of 2% to £47.3m, with profit before tax and highlighted items falling to £5.9m from £7.1m a year earlier.

The company's Academic and Professional division generated revenue of £36.4m, with profit before tax and highlighted items at £5.9m.

Meanwhile, Bloomsbury Digital Resources (BDR) revenue amounted to £13.3m for the period, with the company on track to achieve its new BDR target of 40% organic revenue growth over the five years leading up to 2027-2028.

"Bloomsbury achieved our fourth consecutive double-digit growth in revenue and profit in the first half," said chief executive officer Nigel Newton.

"These are also our highest ever first half results, with year-on-year revenue growth of 11% to £136.7m and profit growth of 11% to £17.7m.

"These results demonstrate the strength of our strategy of publishing for both the consumer and academic markets."

Newton described fantasy as a "huge and increasingly popular" genre that had driven the firm's consumer division forward.

"Sales of Sarah J. Maas and Samantha Shannon grew 79% and 169% respectively in the period, and demand for Harry Potter, 26 years after publication, remains strong.

"The consumer division revenue grew by 17%, achieving a 26% increase in profit before tax and highlighted items to £11.2m.

"Bloomsbury Digital Resources (BDR) consolidated last year's exceptional growth and increased subscription revenue to 47%."

The non-consumer division's "resilient performance", with 2% revenue growth and £5.9m of profit before tax and highlighted items, demonstrated what Nigel Newton called the strength of Bloomsbury's long-term academic strategy.

"Since the period end, Bloomsbury author Jon Fosse won the most important prize in the literary world, the Nobel Prize in Literature, becoming the eighth Nobel Prize winner on Bloomsbury's Methuen Drama list.

"Bloomsbury's successful strategy of diversifying across formats, markets and territories has created a stronger and more balanced business and a smoother earnings profile across the year.

"Recognising this, and in view of a better balance between sales in the first and second halves of the year than in the past when we were more heavily weighted to the second half and the Christmas market, we are increasing the proportion of the full year dividend paid at the interim."

Newton said Bloomsbury was maintaining its overall dividend guidance for the whole year.

"The strong first half performance means that we are confident of achieving the board's expectations for the year ending 29 February.

"Our strong financial position, with net cash of £39.1m, gives us significant opportunities for further acquisitions and investment in organic growth."

Bloomsbury said it considered current consensus market expectation for the year ending 29 February to be revenue of £273.1m and profit before tax and highlighted items of £32.5m.

At 0859 BST, shares in Bloomsbury Publishing were up 1.41% at 409.68p.

Reporting by Josh White for Sharecast.com.

More News
26 Mar 2018 21:56

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 07:23

UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success

ZURICH, March 26 (Reuters) - Roche's immunotherapy Tecentriq combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss trial

Read more
25 Mar 2018 14:15

Israel to launch Big Data health project

By Maayan Lubell JERUSALEM, March 25 (Reuters) - Israel will invest nearly 1 billion shekels ($287 million) in a to a

Read more
20 Mar 2018 07:05

UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer

ZURICH, March 20 (Reuters) - Roche's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in advanced squamous lung cancer, but it did not

Read more
19 Mar 2018 17:59

Bloomsbury Publishing Expecting Profitability To Beat Expectations

LONDON (Alliance News) - Bloomsbury Publishing PLC said on Monday it expects its full-year profit and revenue to both be ahead of expectations.For the year ending 28 to

Read more
20 Jan 2017 09:08

Bloomsbury Publishing Says Chairman Salz To Step Down In July

Read more
27 Oct 2016 07:43

Bloomsbury Publishing Sees Stronger Second Half As Trading In Line

Read more
13 Jul 2016 12:55

Bloomsbury Publishing plots expansion into B2B market

(ShareCast News) - Harry Potter publisher Bloomsbury Publishing held a capital markets day for investors and analysts on Wednesday to present plans to enter the business-to-business market, while also confirming first-quarter trading remained in line with full year expectations. Bloomsbury unveiled

Read more
13 Jul 2016 08:20

Bloomsbury Publishing Says Full Year Trading To Meet Expectations

Read more
12 Jul 2016 15:11

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Jul 2016 15:00

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 May 2016 12:43

Bloomsbury moves towards digital B2B after strong FY

(ShareCast News) - Bloomsbury, the publisher behind the Harry Potter phenomenon, has turned in an overall strong set of full-year results and launched a 2020 strategy to move into digital B2B publishing. It booked a full-year pretax profit of £10.36m, from a year-earlier profit of £9.60m, with reven

Read more
19 May 2016 08:18

Bloomsbury To Reoganise Divisions As Profit Lifted By Children's Books

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.